Amend CSSB 1188 (House Committee Printing) by adding the 
following appropriately numbered SECTION to the bill and 
renumbering subsequent SECTIONS of the bill accordingly:
	SECTION __.  PRESCRIPTION DRUGS.  (a)  Section 531.070, 
Government Code, is amended by adding Subsection (n) to read as 
follows:
	(n)  Before entering into a supplemental rebate agreement 
with a manufacturer, the commission shall disclose to the 
manufacturer any clinical edits or clinical protocols that the 
commission knows might be imposed during the term of the agreement 
on a particular class of drugs on the preferred drug list adopted 
under Section 531.072 that applies under the Medicaid vendor drug 
program.  If the commission does not disclose a clinical edit or 
clinical protocol as required by this subsection that would 
otherwise apply to a drug that is manufactured by the manufacturer 
and that will be provided under the Medicaid vendor drug program, 
the clinical edit or clinical protocol may not be imposed on the 
drug during the term of the agreement.
	(b)  Section 531.070(n), Government Code, as added by this 
section, applies only to a supplemental rebate agreement that is 
entered into or renewed on or after the effective date of this Act.  
A supplemental rebate agreement that is entered into or renewed 
before the effective date of this Act is governed by the law in 
effect on the date the agreement was entered into or renewed, and 
the former law is continued in effect for that purpose.